Toragen, Inc. announces FDA acceptance of IND application for TGN-S11 for the treatment of HPV-induced cancers March 6, 2023 Categories: Health Care Tags: Toragen
Toragen, Inc. announces appointment of Chief Scientific Officer February 9, 2023 Categories: Health Care Tags: Toragen
Toragen, Inc. announces appointment of Dr. Sandra Coufal, M.D. as CEO February 11, 2022 Categories: Health Care Tags: Toragen
